Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Courtwright

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Clinical Transplantation|August 17, 2019
Discharge frailty following lung transplantationAndrew M Courtwright, Derek Zaleski, Michael Tevald, et al.
Annals of the American Thoracic Society|April 27, 2019
Clinical Outcomes of Lung Transplantation in the Presence of Donor-Specific AntibodiesAndrew M Courtwright, Severine Cao, Isabelle Wood, et al.
Psychosomatics|December 9, 2019
Ethics Consultations Related to Opioid Use DisorderJulia I Bandini, Andrew M Courtwright, Emily Rubin, et al.
HEC Forum : an Interdisciplinary Journal on Hospitals' Ethical and Legal Issues|November 2, 2020
Experience with a Revised Hospital Policy on Not Offering Cardiopulmonary ResuscitationAndrew M Courtwright, Emily Rubin, Kimberly S Erler, et al.
Clinical Transplantation|March 14, 2020
Mortality trends around the one-year survival mark after heart, liver, and lung transplantation in the United StatesAshwin S Nathan, Catherine Blebea, Paula Chatterjee, et al.
ERJ Open Research|October 15, 2025
Evaluation of a screening protocol for telomere biology disorders in individuals with interstitial lung disease undergoing lung transplant evaluationDaisy Zhu, Namrata B Patel, Allyson M Pishko, et al.
Clinical Transplantation|July 23, 2025
Long-Term Chronic Lung Allograft Dysfunction-Free Survival Following Lung Transplant in the Presence of Donor-Specific AntibodiesBenjamin Grobman, Andrew M Courtwright, Melissa Yeung, et al.
ERJ Open Research|June 25, 2020
Shorter telomere length following lung transplantation is associated with clinically significant leukopenia and decreased chronic lung allograft dysfunction-free survivalAndrew M Courtwright, Anthony M Lamattina, Mai Takahashi, et al.
Clinical Transplantation|June 18, 2016
Predictors and outcomes of unplanned early rehospitalization in the first year following lung transplantationAndrew M Courtwright, Stacey Salomon, Anne Fuhlbrigge, et al.
Physical Therapy|May 30, 2023
Rehabilitation Characteristics and Outcomes for Lung Transplantation for COVID-19: A Case SeriesMalachy J Clancy, Joe Adler, Michael A Tevald, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Clinical Transplantation|August 17, 2019
Discharge frailty following lung transplantationAndrew M Courtwright, Derek Zaleski, Michael Tevald, et al.
Annals of the American Thoracic Society|April 27, 2019
Clinical Outcomes of Lung Transplantation in the Presence of Donor-Specific AntibodiesAndrew M Courtwright, Severine Cao, Isabelle Wood, et al.
Psychosomatics|December 9, 2019
Ethics Consultations Related to Opioid Use DisorderJulia I Bandini, Andrew M Courtwright, Emily Rubin, et al.
HEC Forum : an Interdisciplinary Journal on Hospitals' Ethical and Legal Issues|November 2, 2020
Experience with a Revised Hospital Policy on Not Offering Cardiopulmonary ResuscitationAndrew M Courtwright, Emily Rubin, Kimberly S Erler, et al.
Clinical Transplantation|March 14, 2020
Mortality trends around the one-year survival mark after heart, liver, and lung transplantation in the United StatesAshwin S Nathan, Catherine Blebea, Paula Chatterjee, et al.
ERJ Open Research|October 15, 2025
Evaluation of a screening protocol for telomere biology disorders in individuals with interstitial lung disease undergoing lung transplant evaluationDaisy Zhu, Namrata B Patel, Allyson M Pishko, et al.
Clinical Transplantation|July 23, 2025
Long-Term Chronic Lung Allograft Dysfunction-Free Survival Following Lung Transplant in the Presence of Donor-Specific AntibodiesBenjamin Grobman, Andrew M Courtwright, Melissa Yeung, et al.
ERJ Open Research|June 25, 2020
Shorter telomere length following lung transplantation is associated with clinically significant leukopenia and decreased chronic lung allograft dysfunction-free survivalAndrew M Courtwright, Anthony M Lamattina, Mai Takahashi, et al.
Clinical Transplantation|June 18, 2016
Predictors and outcomes of unplanned early rehospitalization in the first year following lung transplantationAndrew M Courtwright, Stacey Salomon, Anne Fuhlbrigge, et al.
Physical Therapy|May 30, 2023
Rehabilitation Characteristics and Outcomes for Lung Transplantation for COVID-19: A Case SeriesMalachy J Clancy, Joe Adler, Michael A Tevald, et al.
Pageof 7